Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72611 record(s)

Req # A-2019-001695

Adverse Reaction Report (AER). Report numbers: E2B_02743119, E2B_02755588.

Organization: Health Canada

34 page(s)
March 2020

Req # A-2019-001699

Adverse Reaction Report (AER). Report number: E2B_02777706.

Organization: Health Canada

10 page(s)
March 2020

Req # A-2019-001702

Adverse Reaction Report (AER). Report number: E2B_02814214.

Organization: Health Canada

7 page(s)
March 2020

Req # A-2019-001718

Adverse Reaction Report (AER) for Dexedrine. Report number: E2B_02738940. AER for pdp-Hydrocodone. Report number: 726402.

Organization: Health Canada

11 page(s)
March 2020

Req # A-2019-001724

Adverse Reaction Report (AER) for Mesalazine. Report numbers: E2B_02700969, 000728070, 000728071, 000728455, 000728458, E2B_02661335, E2B_02674355, 000729330, 000729337, 000729356, 000729421, 000729425.

Organization: Health Canada

88 page(s)
March 2020

Req # A-2019-001735

Adverse Reaction Report (AER) for IXAZOMIB. Report numbers: E2B_02767945, E2B_02767418.

Organization: Health Canada

24 page(s)
March 2020

Req # A-2019-001752

Adverse Reaction Report (AER) for DOCUSATE SODIUM. Report numbers: 725417, E2B_02430183, E2B_02432728.

Organization: Health Canada

29 page(s)
March 2020

Req # A-2019-001778

Adverse Reaction Report (AER). Report numbers: E2B_02600454, E2B_02700179, E2B_02728137, E2B_02803267.

Organization: Health Canada

42 page(s)
March 2020

Req # A-2019-001817

Adverse Reaction Report (AER). Report number: E2B_02660917.

Organization: Health Canada

12 page(s)
March 2020

Req # A-2019-001820

Adverse Reaction Report (AER). Report number: E2B_02769603.

Organization: Health Canada

25 page(s)
March 2020
Date modified: